As real estate continues to evolve…

One ticker that’s been consistently delivering winners for us inside The War Room is Zillow (Z).

As I’m sure you know, Zillow operates a series of online and mobile real estate brands. These offer you the ability to quickly and easily gather information on real estate prices, get connected with brokers and view virtual tours… all from the palm of your hand.

I can tell you from experience: Zillow is the premier place to track what your neighbor paid for their house back in 2015 or see what that overpriced monstrosity on the corner finally sold for.

The company operates through three segments: Internet, Media and Technology (IMT); Mortgages; and Homes.

• Its IMT segment offers a marketplace for buyers, renters and agents, a new construction marketplace, and 3D interactive floor plans.
• Its Mortgages segment provides mortgage originations, mortgage sales and advertising to mortgage lenders.
• Its Homes segment offers title and escrow services.

Zillow reported earnings last week, and despite the stock dropping initially and summer sales volumes being lower than usual due to high mortgage rates, there were some clear signs of strength.

The company reported revenue of $506 million and adjusted earnings per share of $0.39. But here’s what I really liked…

CEO Rich Barton and CFO Jeremy Hofmann said Zillow wants to become “the housing super app” – that is, a central hub for all things real estate-related.

To me, this sets a strong vision for the company going forward.

Zillow expects this strategy to double its share of customer transactions from 3% to 6% by the end of 2025.

Meanwhile, Zillow’s revenue from rentals increased 28% to $91 million for the quarter. The company benefited from lower rental demand and greater supply, which drove landlords to the company to advertise.

And as you can see, the stock has been responding in a very consistent upside pattern…

YOUR ACTION PLAN

Because of the future vision it has in place, I believe that Zillow (Nasdaq: Z) will quickly emerge as the one-stop shop for all real estate transactions – which would make the shares a “Buy” at current levels.

We’ve traded Z inside The War Room with consistent success. If you’d like to be a part of these kinds of trades, you’re invited to join us “in the room” by clicking HERE.

MONDAY MARKET MINUTE

• Sage Therapeutics Presents Opportunity. Late in the day last Friday, the FDA approved Sage Therapeutics‘ (SAGE) drug Zurzuvae, which is the first and only oral treatment approved for women with postpartum depression. Shares are down 50%, but only because Zurzuvae hasn’t yet received FDA approval as a treatment for clinical depression. This could be an opportunity. Tracking.
• Chevron in for a Spike. Oil prices recently rose to four-month highs before giving up ground. Ukraine also attacked a key port for Russian oil exports over the weekend. Russia is the world’s second-largest crude oil exporter, so further escalation of this conflict could trigger a possible spike in plays like Chevron (CVX).
• Sovos Brands Up in Premarket. Sovos Brands (SOVO) was up 25% this morning after entering an agreement for Campbell Soup (CPB) to acquire the company for $23 per share in cash.
• Tabula Rasa HealthCare Gets a Boost. Tabula Rasa HealthCare (TRHC) was up 32% this morning after agreeing to be acquired by Nautic Partners for $10.50 in cash per share and combine with ExactCare Pharmacy.